Buy Goldman-Cecil. Tratado de medicina interna 26th Edition PDF ebook by author Elsevier – published by Elsevier in 2021 and save up to 80% compared to the print version of this textbook. With PDF version of this textbook, not only save you money, you can also highlight, add text, underline add post-it notes, bookmarks to pages, instantly search for the major terms or chapter titles, etc.
You can search our site for other versions of the Goldman-Cecil. Tratado de medicina interna 26th Edition PDF ebook. You can also search for others PDF ebooks from publisher Elsevier, as well as from your favorite authors. We have thousands of online textbooks and course materials (mostly in PDF) that you can download immediately after purchase.
Note: e-textBooks do not come with access codes, CDs/DVDs, workbooks, and other supplemental items.
eBook Details:
Full title: Goldman-Cecil. Tratado de medicina interna 26th Edition
Edition: 26th
Copyright year: 2021
Publisher: Elsevier
Author: Elsevier
ISBN: 9788491137658, 9783030520212
Format: PDF
Description of Goldman-Cecil. Tratado de medicina interna 26th Edition:
This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.
